Oxford Immunotec Glo...
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
Oxford Immunotec Global PLC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 445 (as per Q2 2016)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker OXFDno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1712,013,515,016,518,0
datesClosing price (adj.)
13.10.201716.85
11.10.201716.90
04.10.201716.89
27.09.201716.76
20.09.201715.73
13.09.201715.28
06.09.201715.38
30.08.201715.50
23.08.201714.81
16.08.201716.13
09.08.201717.38
02.08.201717.87
26.07.201716.21
19.07.201716.71
12.07.201717.05
05.07.201716.26
27.06.201715.87
20.06.201714.85
13.06.201714.54
06.06.201714.46
30.05.201714.00
23.05.201714.12
16.05.201714.44
09.05.201714.50
02.05.201715.11
25.04.201715.39
18.04.201715.37
11.04.201715.43
04.04.201715.33
28.03.201715.50
21.03.201715.35
14.03.201714.99
07.03.201714.97
28.02.201713.51
21.02.201713.45
14.02.201713.48
07.02.201713.35
31.01.201713.51
24.01.201713.47
17.01.201713.40
10.01.201714.58
03.01.201714.70
27.12.201614.92
19.12.201614.91
12.12.201615.00
05.12.201615.00
28.11.201614.70
21.11.201614.57
14.11.201614.23
07.11.201614.28
31.10.201612.86
24.10.201613.01
17.10.201613.05
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 16.85n/a
Market Capitalisation
in million USD
 380n/a
Enterprise Value
in million USD
 440n/a
Common Shares Outstanding
as per Jul 27, 2016
 22,569,881n/a
Preferred Shares Outstanding
as per Jul 27, 2016
 7,301,321n/a
Average Basic Shares Outstanding
TTM
 21,781,933n/a
Average Diluted Shares Outstanding
TTM
 22,296,669n/a
Index Membership
n/a
Business Summary
Oxford Immunotec Global PLC is a high-growth diagnostics company. It is engaged in developing and commercializing proprietary tests for the management of immune-regulated conditions. Its platform includes T-SPOT technology platform.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 71n/a
Gross Profit 38n/a
Operating Income -26n/a
EBITDA -23n/a
Net Profit -24n/a
Balance Sheet
Cash and Cash Equivalents 64n/a
Receivables 10n/a
Total Current Assets 85n/a
PP&E 7n/a
Total Assets 94n/a
Accounts Payable 3n/a
Current Debt 0n/a
Total Current Liabilities 11n/a
Long-Term Debt 0n/a
Total Liabilities 13n/a
Total Equity 80n/a
Cash Flow
Depreciation & Amortisation 2n/a
Change in Working Capital -5n/a
Operating Cash Flow -22n/a
Net Change in PP&E and Intangibles -3n/a
Investing Cash Flow -3n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash -26n/a
Free Cash Flow -32n/a
Profitability Ratios
Gross Margin 53.3%n/a
Operating Margin -36.0%n/a
Net Profit Margin -34.3%n/a
Return on Equity -30.3%n/a
Return on Assets -26.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS -1.09n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA -18.98n/a
EV/Sales 6.19n/a
Book to Market Value 0.21n/a
Other Ratios
Current Ratio 739.7%n/a
Liabilities to Equity Ratio 16.5%n/a
Debt to Assets Ratio 0.4%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Revenue
21
39
50
63
Sales & Services Revenue
0
0
0
0
Financing Revenue
0
0
0
0
Other Revenue
0
0
0
0
Cost of revenue
-12
-19
-24
-30
Cost of Goods & Services
0
0
0
0
Cost of Financing Revenue
0
0
0
0
Cost of Other Revenue
0
0
0
0
Gross Profit
8
20
25
33
Other Operating Income
0
0
0
0
Operating Expenses
-21
-28
-47
-57
Selling, General & Administrative
-19
-25
-40
-46
Selling & Marketing
0
0
0
0
General & Administrative
0
0
0
0
Research & Development
-2
-2
-7
-11
Depreciation & Amortization
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
Other Operating Expense
0
0
0
0
Operating Income (Loss)
-13
-7
-22
-24
Non-Operating Income (Loss)
-2
-1
0
0
Interest Expense, net
-1
0
0
0
Interest Expense
0
0
0
0
Interest Income
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
Foreign Exchange Gain (Loss)
-1
0
0
0
Income (Loss) from Affiliates
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
Pretax Income (Loss), Adjusted
-15
-9
-22
-24
Abnormal Gains (Losses)
0
0
0
0
Acquired In-Process R&D
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
Abnormal Derivatives
0
0
0
0
Disposal of Assets
0
0
0
0
Early extinguishment of Debt
0
0
0
0
Asset Write-Down
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
Sale of Business
0
0
0
0
Legal Settlement
0
0
0
0
Restructuring Charges
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
Insurance Settlement
0
0
0
0
Other Abnormal Items
0
0
0
0
Pretax Income (Loss)
-15
-9
-22
-24
Income Tax (Expense) Benefit, net
0
0
0
0
Current Income Tax
0
0
0
0
Deferred Income Tax
0
0
0
0
Tax Allowance/Credit
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
Income (Loss) from Continuing Operations
-15
-9
-22
-24
Net Extraordinary Gains (Losses)
0
0
0
0
Discontinued Operations
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
Income (Loss) Including Minority Interest
-15
-9
-22
-24
Minority Interest
0
0
0
0
Net Income
-15
-9
-22
-24
Preferred Dividends
0
0
0
0
Other Adjustments
0
0
0
0
Net Income Available to Common Shareholders
-15
-9
-22
-24
Remarks
restated on Mar 5, 2015 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
76
50
84
Cash & Cash Equivalents
n/a
76
50
84
Short Term Investments
n/a
0
0
0
Accounts & Notes Receivable
n/a
5
7
7
Accounts Receivable, Net
n/a
5
7
7
Notes Receivable, Net
n/a
0
0
0
Unbilled Revenues
n/a
0
0
0
Inventories
n/a
5
6
7
Raw Materials
n/a
0
0
0
Work In Process
n/a
0
0
0
Finished Goods
n/a
0
0
0
Other Inventory
n/a
0
0
0
Other Short Term Assets
n/a
2
3
4
Prepaid Expenses
n/a
2
3
4
Derivative & Hedging Assets
n/a
0
0
0
Assets Held-for-Sale
n/a
0
0
0
Deferred Tax Assets
n/a
0
0
0
Income Taxes Receivable
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
Total Current Assets
n/a
89
66
101
Property, Plant & Equipment, Net
n/a
3
5
6
Property, Plant & Equipment
n/a
0
0
0
Accumulated Depreciation
n/a
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
Long Term Investments
n/a
0
0
0
Long Term Marketable Securities
n/a
0
0
0
Long Term Receivables
n/a
0
0
0
Other Long Term Assets
n/a
1
3
2
Intangible Assets
n/a
0
0
0
Goodwill
n/a
0
0
0
Other Intangible Assets
n/a
0
0
0
Prepaid Expense
n/a
0
0
0
Deferred Tax Assets
n/a
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
Prepaid Pension Costs
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Investments in Affiliates
n/a
0
0
0
Miscellaneous Long Term Assets
n/a
0
3
2
Total Noncurrent Assets
n/a
4
7
8
Total Assets
n/a
93
74
110
Liabilities and owners' equity
Payables & Accruals
n/a
9 9423000
9 9438000
14 13748000
Accounts Payable
n/a
2 2310000
2 2368000
4 3799000
Accrued Taxes
n/a
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
Other Payables & Accruals
n/a
7 7113000
7 7070000
10 9949000
Short Term Debt
n/a
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
Other Short Term Liabilities
n/a
2 1710000
2 2130000
2 1733000
Deferred Revenue
n/a
2 1540000
2 1993000
2 1654000
Derivatives & Hedging
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 170000
0 137000
0 79000
Total Current Liabilities
n/a
11 11133000
12 11568000
15 15481000
Long Term Debt
n/a
1 563000
0 454000
0 386000
Long Term Borrowings
n/a
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
Other Long Term Liabilities
n/a
0 296000
1 1218000
1 1293000
Accrued Liabilities
n/a
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 296000
1 1218000
1 1293000
Total Noncurrent Liabilities
n/a
1 859000
2 1672000
2 1679000
Total Liabilities
n/a
12 11992000
13 13240000
17 17160000
Preferred Equity
n/a
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
184 184155000
187 187008000
244 244276000
Common Stock
n/a
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
Retained Earnings
n/a
-100 -99655000
-122 -121829000
-146 -146307000
Other Equity
n/a
-4 -3748000
-5 -4570000
-5 -5277000
Equity Before Minority Interest
n/a
81 80752000
61 60609000
93 92692000
Minority Interest
n/a
0 0
0 0
0 0
Total Equity
n/a
81 80752000
61 60609000
93 92692000
Total Liabilities & Equity
n/a
93 92744000
74 73849000
110 109852000
Remarks restated on n/a restated on Mar 5, 2015 n/a restated on Mar 1, 2016 n/a restated on Aug 2, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Net Income/Starting Line
-15
-9
-22
-24
Net Income
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
Other Adjustments
0
0
0
0
Depreciation & Amortization
1
1
2
2
Non-Cash Items
2
1
3
4
Stock-Based Compensation
0
0
0
0
Deferred Income Taxes
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
Change in Working Capital
-2
1
-3
2
(Increase) Decrease in Accounts Receivable
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
Cash from Operating Activities
-14
-6
-21
-17
Change in Fixed Assets & Intangibles
-2
-2
-3
-3
Disposition of Fixed Assets & Intangibles
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
Increase in Long Term Investment
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
-2
0
Net Cash from Divestitures
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
Cash for Joint Ventures
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
Other Investing Activities
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
Cash from Investing Activities
-2
-2
-5
-3
Dividends Paid
0
0
0
0
Cash From (Repayment of) Debt
14
4
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
Cash From Long Term Debt
0
0
0
0
Cash From (Repurchase of) Equity
13
67
0
54
Increase in Capital Stock
0
0
0
0
Decrease in Capital Stock
0
0
0
0
Other Financing Activities
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
Cash from Financing Activities
26
71
0
54
Net Cash Before Disc. Operations and FX
10
63
-26
34
Change in Cash from Disc. Operations and Other
0
0
0
0
Net Cash Before FX
10
63
-26
34
Effect of Foreign Exchange Rates
0
1
0
0
Net Changes in Cash
10
64
-26
34
Remarks
restated on Mar 5, 2015 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo